Orchid Pharma Ltd - 524372 - Explanation For The Delay Under Regulation 30 Regarding The Intimation Dated December 14, 2023 Submitted By The Company.
The delay in intimation dated December 14, 2023 under Regulation 30 was caused inadvertently due to interpretation difference under relevant clauses of Schedule III of Listing Regulation. Orchid Pharma Ltd - 524372 - Closure of Trading Window
Trading Window will remain closed from April 01, 2024 til 48 hours after the declaration of the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ending on March 31, 2024. Orchid Pharma Ltd - 524372 - Intimation Regarding The Appeal Filed By The Company Against The Order Passed By 'ASSISTANT COMMISSIONER VALLUVARKOTTAM ASSESSMENT CIRCLE' W.R.T The Audit Conducted Under Section 65 For The Period 2017-18.
In reference to the disclosure submitted by the Company dated January 31, 2024, we would like to inform that the Company has filed an appeal before the GST Appeals Chennai-1 against the subjected order. Orchid Pharma Ltd - 524372 - Investor Roadshow Schedule
Pursuant to Regulation 30 of Listing Regulation this is to inform that a Investor Roadshow is scheduled to be held on February 29, 2024 in Mumbai.
Orchid Pharma - Enmetazobactam, First Indian NCE Gets U.S. FDA Nod: Systematix
We revise our target price on Orchid pharma at Rs. 1,057 as we raise our target price-to-earnings multiple from 30 times to 33 times. Orchid Pharma's Exblifep gets USFDA approval; stock surges
The company based in Chennai has received the United States Food and Drug Administration (USFDA) approval Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the Press Release being released titled "Orchid Pharma''s ''Exblifep'' receives USFDA approval: A new milestone for India''s Pharmaceutical industry Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Earning Call Transcript Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Monitoring Agency Report Orchid Pharma Q3 Results Review - Big Surprise On Margins: Systematix
Orchid Pharma reported a strong set of numbers both YoY and QoQ.